RAC 2.20% $1.78 race oncology ltd

I think the best move is a compound that can service the...

  1. 1,232 Posts.
    lightbulb Created with Sketch. 12282
    I think the best move is a compound that can service the obesity-associated disease market through the regulation of m6A. This ensures RAC is a non-communicable diseases m6A mRNA platform play. There is plenty of information coming out linking markers of disease and drug targets to dysregulated m6A epitranscriptomic proteins.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.